| RS1555761934 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1555761969 |
CSNK2A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555761997 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555762070 |
ETHE1
|
Health Risk |
Likely pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1555762381 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555762532 |
RYR1
|
Health Risk |
Likely pathogenic |
Rhabdomyolysis, Rhabdomyolysis |
| RS1555762591 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555762722 |
ETHE1
|
Health Risk |
Likely pathogenic |
Ethylmalonic encephalopathy, Abnormality of the nervous system |
| RS1555762734 |
CSNK2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Okur-Chung neurodevelopmental syndrome |
| RS1555762737 |
CSNK2A1
|
Health Risk |
Pathogenic |
— |
| RS1555762753 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1555762855 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1555762869 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1555762908 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1555763090 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555763342 |
MAG
|
Health Risk |
Likely pathogenic |
— |
| RS1555763372 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555763460 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555763503 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555763603 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Nephrotic syndrome |
| RS1555763642 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555763657 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1555763737 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1555763780 |
SMARCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555763943 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555763974 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555763998 |
TCF4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555764014 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS1555764170 |
TCF4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555764281 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555764460 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS1555764797 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555764839 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555764960 |
ARSG
|
Health Risk |
Likely pathogenic |
— |
| RS1555764992 |
CSNK2A1
|
Health Risk |
Likely pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS1555765151 |
CIC
|
Health Risk |
Likely pathogenic |
— |
| RS1555765524 |
ETHE1
|
Health Risk |
Likely pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1555765593 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1555765689 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1555765701 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1555766066 |
BCKDHA
|
Health Risk |
Likely pathogenic |
— |
| RS1555766993 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1555767028 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease |
| RS1555767090 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS1555767169 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1555767285 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1555767403 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1555767678 |
TNFRSF11A
|
Health Risk |
Pathogenic |
Paget disease of bone 2, early-onset |
| RS1555767914 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS1555767930 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS1555768154 |
XRCC1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive 26 |
| RS1555768365 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1555768979 |
STXBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS1555769166 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS1555769289 |
CIC
|
Health Risk |
Pathogenic |
— |
| RS1555769544 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1555769818 |
RYR1
|
Health Risk |
Likely pathogenic |
Distal arthrogryposis, Distal arthrogryposis |
| RS1555769968 |
CIC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS1555770200 |
CIC
|
Health Risk |
Pathogenic |
— |
| RS1555770306 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1555770968 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1555771571 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1555772199 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS1555773152 |
CIC
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555773269 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555773554 |
CIC
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555773764 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Epileptic encephalopathy, Episodic ataxia type 2 |
| RS1555774631 |
SMARCA4
|
Health Risk |
Pathogenic |
— |
| RS1555774702 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555774786 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555774859 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1555775208 |
SNRPA
|
Health Risk |
Likely pathogenic |
Spliceosomepathy, Spliceosomepathy |
| RS1555775209 |
SNRPA
|
Health Risk |
Likely pathogenic |
Spliceosomepathy, Spliceosomepathy |
| RS1555775233 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555775416 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, ERCC2-related disorder |
| RS1555775708 |
ERCC2
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS1555775774 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1555776677 |
ERCC2
|
Health Risk |
Likely pathogenic |
— |
| RS1555777043 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1555777086 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1555778204 |
TCF4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555778709 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1555778797 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Intellectual disability |
| RS1555778812 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1555778828 |
SMARCA4
|
Health Risk |
Pathogenic |
— |
| RS1555778830 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555778883 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 16 |
| RS1555779353 |
NOP56
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 36, Spinocerebellar ataxia type 36 |
| RS1555779450 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1555779547 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555779989 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555780015 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Intellectual disability |
| RS1555780327 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS1555781050 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555781271 |
IDH3B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1555781739 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1555781806 |
KCNC3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 13, Spinocerebellar ataxia type 13 |
| RS1555782101 |
PRNP
|
Health Risk |
Pathogenic |
CEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED |
| RS1555782724 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1555782866 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |